Urtica dioica extracts abolish scopolamine-induced neuropathies in rats
- PMID: 33405105
- DOI: 10.1007/s11356-020-12025-y
Urtica dioica extracts abolish scopolamine-induced neuropathies in rats
Abstract
Alzheimer's disease (AD) is characterized by alterations in monoamines, oxidative stress, and metabolic dysfunctions. We aim to assess the therapeutic impacts of roots or leaf extract from Urtica dioica (UD; stinging nettle) against scopolamine (SCOP)-induced memory dysfunction, amnesia, and oxidative stress in rats. Spatial memory was assessed by Y maze test. Tissue analyses of norepinephrine (NE), dopamine (DA), serotonin (5-HT), malondialdehyde (MDA), nitric oxide (NO), glutathione (GSH, GSSG), AMP, ADP, and ATP were assessed by HPLC. mRNA levels of Tau and Hsp70 were estimated by PCR. UD extracts particularly nettle root (NR) significantly normalized the SCOP-induced memory deficits even more potent than sermion (SR) and donepezil (DON). Similarly, NR had potent therapeutic impacts on the levels of cortical and hippocampal monoamines e.g. DA, NE, and 5-HT. SCOP induced a dramatic oxidative stress as measured by MDA, NO, and GSSG levels; however, UD extracts showed significant anti-oxidative stress impacts. Additionally, UD extracts restored ATP levels and reduced the levels of AMP and ADP compared to SCOP-treated rats. Furthermore, cortical Tau and hippocampal Hsp70 were modulated by UD extracts particularly NR compared to the SCOP group. In conclusion, UD extracts particularly roots have potential therapeutic impacts against SCOP-induced neuroinflammatory and/or Alzheimer-like phenotype in rats.
Keywords: Alzheimer-like phenotype; Monoamines; Neuroinflammation; Oxidative stress; Spatial memory.
Similar articles
-
Exercise and Urtica dioica extract ameliorate hippocampal insulin signaling, oxidative stress, neuroinflammation, and cognitive function in STZ-induced diabetic rats.Biomed Pharmacother. 2021 Jul;139:111577. doi: 10.1016/j.biopha.2021.111577. Epub 2021 Apr 8. Biomed Pharmacother. 2021. PMID: 33839493
-
Beneficial effects of Urtica dioica on scopolamine-induced memory impairment in rats: protection against acetylcholinesterase activity and neuronal oxidative damage.Drug Chem Toxicol. 2019 Mar;42(2):167-175. doi: 10.1080/01480545.2018.1463238. Epub 2018 May 10. Drug Chem Toxicol. 2019. PMID: 29745257
-
Effect of Camellia sinensis, Hypericum perforatum and Urtica dioica on kidney and liver injury induced by carbon tetrachloride in rats.Cell Mol Biol (Noisy-le-grand). 2019 Jun 30;65(5):79-86. Cell Mol Biol (Noisy-le-grand). 2019. PMID: 31304911
-
Screening of pharmacological uses of Urtica dioica and others benefits.Prog Biophys Mol Biol. 2020 Jan;150:67-77. doi: 10.1016/j.pbiomolbio.2019.05.008. Epub 2019 Jun 1. Prog Biophys Mol Biol. 2020. PMID: 31163183 Review.
-
Urtica dioica: Anticancer Properties and Other Systemic Health Benefits from In Vitro to Clinical Trials.Int J Mol Sci. 2024 Jul 8;25(13):7501. doi: 10.3390/ijms25137501. Int J Mol Sci. 2024. PMID: 39000608 Free PMC article. Review.
Cited by
-
Modulatory Effects of Urtica dioica on Neurodegenerative Diseases: Unveiling the Latest Findings and Applications Related to Neuroinflammation, Oxidative Stress, and Cognitive Dysfunction.Antioxidants (Basel). 2025 Jul 12;14(7):854. doi: 10.3390/antiox14070854. Antioxidants (Basel). 2025. PMID: 40722958 Free PMC article. Review.
-
Ambroxol confers neuroprotection against scopolamine-induced Alzheimer's-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways.Front Aging Neurosci. 2025 Jul 23;17:1607289. doi: 10.3389/fnagi.2025.1607289. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40771195 Free PMC article.
-
Biological Evaluation of Valeriana Extracts from Argentina with Potent Cholinesterase Inhibition for the Treatment of Neurodegenerative Disorders and Their Comorbidities-The Case of Valeriana carnosa Sm. (Caprifoliaceae) Studied in Mice.Pharmaceuticals (Basel). 2023 Jan 16;16(1):129. doi: 10.3390/ph16010129. Pharmaceuticals (Basel). 2023. PMID: 36678626 Free PMC article.
-
Neuroprotective and antioxidant effects of Urtica dioica extract against chlorpyrifos-induced toxicity: an in vivo study.3 Biotech. 2025 Apr;15(4):86. doi: 10.1007/s13205-025-04239-z. Epub 2025 Mar 12. 3 Biotech. 2025. PMID: 40092451
-
Research on Alzheimer's Disease (AD) Involving the Use of In vivo and In vitro Models and Mechanisms.Cent Nerv Syst Agents Med Chem. 2025;25(2):123-142. doi: 10.2174/0118715249293642240522054929. Cent Nerv Syst Agents Med Chem. 2025. PMID: 38803173 Review.
References
-
- Abd-El-Fattah MA, Abdelakader NF, Zaki HF (2014) Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats. Eur J Pharmacol 723:330–338. https://doi.org/10.1016/j.ejphar.2013.11.008 - DOI
-
- Arafa NM, Ali EH, Hassan MK (2017) Canagliflozin prevents scopolamine-induced memory impairment in rats: comparison with galantamine hydrobromide action. Chem Biol Interact. 277:195–203. https://doi.org/10.1016/j.cbi.2017.08.013 - DOI
-
- Bélanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14(6):724–738. https://doi.org/10.1016/j.cmet.2011.08.016 - DOI
-
- Bihaqi SW, Singh AP, Tiwari M (2012) Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and amyloid precursor protein (AβPP) expression in rat brain. Indian J Pharmacol. 44(5):593–598. https://doi.org/10.4103/0253-7613.100383 - DOI
-
- Bolea I, Gella A, Unzeta M (2013) Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors. J Neural Transm (Vienna). 120(6):893–902. https://doi.org/10.1007/s00702-012-0948-y - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials